# B010-A Injection for Treating Patients With GPC3 Positive Advanced Hepatocellular Carcinoma

> **NCT05070156** · EARLY_PHASE1 · UNKNOWN · sponsor: **Tongji University** · enrollment: 3 (actual)

## Conditions studied

- Advanced Hepatocellular Carcinoma

## Interventions

- **BIOLOGICAL:** Biological/Vaccine: Low-dose group
- **BIOLOGICAL:** Biological/Vaccine: Mid-dose group
- **BIOLOGICAL:** Biological/Vaccine: High-dose group

## Key facts

- **NCT ID:** NCT05070156
- **Lead sponsor:** Tongji University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-10-29
- **Primary completion:** 2024-08-31
- **Final completion:** 2024-09-30
- **Target enrollment:** 3 (ACTUAL)
- **Last updated:** 2023-12-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05070156

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05070156, "B010-A Injection for Treating Patients With GPC3 Positive Advanced Hepatocellular Carcinoma". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT05070156. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*